| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |